Autologous haematopoietic-stem-cell transplantation for multiple sclerosis (Q35994389)

11 August 2017

1 reference

title

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis (English)

1 reference

11 August 2017

0 references

3

Enric Carreras

1 reference

11 August 2017

Yolanda Blanco

1

1 reference

PubMed ID

15620857

11 August 2017

Albert Saiz

series ordinal

2

1 reference

PubMed ID

15620857

11 August 2017

Francesc Graus

series ordinal

4

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

1

1 reference

11 August 2017

54-63

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

11 August 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

1 reference

7 January 2021

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Bone marrow transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Bone marrow transplantation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Autologous stem cell transplantation for treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

The effect of pretreatment of allogeneic bone marrow graft recipients with antilymphocytic serum on the acute graft-versus-host reaction in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Post-transplant lymphoproliferative disorder: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Stem cell transplantation for multiple sclerosis: What is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Effect of brain irradiation on demyelinating lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Role of enhanced MRI in the follow-up of patients with medically refractory trigeminal neuralgia undergoing stereotactic radiosurgery using the gamma knife: initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Clinical exacerbation of multiple sclerosis following radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Solid cancers after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Trends in survival and cause of death in Danish patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Autoantibody Formation After Bone Marrow Transplantation: A Comparison Between Autologous and Allogeneic Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Complications of autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900966-4

7 January 2021

10.1016/S1474-4422(04)00966-4

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15620857